Clinically Significant Resistance Mutations for Abacavir Unmasked
Clinically Significant Resistance Mutations for Abacavir Unmasked
Carmen de Mendoza
Puerta de Hierro University Hospital, Madrid, Spain
*Correspondence: Carmen de Mendoza, Email not available
Abstract
A recent report has proposed a new approachfor the validation of clinically relevantscores for resistance to antiretroviral drugs. Initiallyit has been applied to abacavir (ABC)(Brun-Vézinet, et al. AIDS 2003;17:1795-802).
